• DVM, MS, PhD, Diplomate American College of Veterinary Pathologists (DACVP).• Immunologist and Veterinary Clinical Pathologist with over 20 years of experience in both academia and pharmaceutical industry.• Highly experienced biomarker team leader and translational medicine with proven record of leadership success in promoting efficient cross-functional collaborations between preclinical and clinical safety scientists. • Substantial expertise in external liaisons and collaborations, and in technology evaluation and assay validation.• Work with internal and external partners to provide scientific leadership in interpreting toxicity and pharmacologic effects.• Senior Pathologist on regulatory GLP and non-GLP toxicology studies, both large and small molecule, from early discovery through marketed compounds.• Support early discovery therapeutic areas with target identification, validation, liability, and mitigation, and efficacy of animal models.• Author / co-author of more than 100 scientific publications.• Section Editor for Veterinary Clinical Pathology.• Member of the ACVP Board Examination Committee, 2013, 2015 and 2018-2020.• Member of the ACVP Board Examination Task Force, 2009-2012.• Member of a CDC special panel to assess past and present performance of the malaria research and to provide recommendations for future research initiatives and projects, 2013.